Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease (Q24618036)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042321

Screening and prevention in Tay-Sachs disease: origins, update, and impact

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042321

Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042321

Effects of patents and licenses on the provision of clinical genetic testing services

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042321

Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042321

Canavan disease: from spongy degeneration to molecular analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042321

cDNA clone for the alpha-chain of human beta-hexosaminidase: deficiency of alpha-chain mRNA in Ashkenazi Tay-Sachs fibroblasts

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042321

Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with canavan disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042321

Tay-Sachs disease: from clinical description to molecular defect.

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A669

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042321

Prenatal diagnosis of Canavan disease--problems and dilemmas

28 November 2018

1 reference

12 December 2020

ACOG committee opinion. Screening for canavan disease. Number 212, November 1998. Committee on Genetics. American College of Obstetricians and Gynecologists

1 reference

12 December 2020

Prenatal diagnosis of Canavan disease

1 reference

12 December 2020

ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent

1 reference

12 December 2020

ACOG committee opinion. Number 318, October 2005. Screening for Tay-Sachs disease

1 reference

12 December 2020

Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population

1 reference

12 December 2020

The National Tay-Sachs and Allied Diseases Association, Inc

1 reference

12 December 2020

Prenatal diagnosis for Canavan disease: the use of DNA markers

1 reference

12 December 2020

Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): comparison of enzymatic and metabolite analysis

1 reference

12 December 2020

20. Screening and prevention in Tay-Sachs disease: Origins, update, and impact

1 reference

Crossref

https://api.crossref.org/works/10.1097%2FGIM.0B013E3181D5A669

7 January 2021